21 results on '"Gopalan, Anuradha"'
Search Results
2. Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer
3. Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer.
4. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
5. Circulating tumor cells (CTCs) with small-cell like pathology are prevalent in metastatic castration-resistant prostate cancer (mCRPC) and show selective pharmacodynamic reductions in patients treated with platinum but not ARSI or taxane.
6. Genomic determinants of nested variant urothelial carcinoma.
7. PD-1 Blockade in Advanced Adrenocortical Carcinoma
8. Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma.
9. Metacure: Multi-arm multimodality therapy for very high risk localized and low volume metastatic prostatic adenocarcinoma.
10. Molecular stratification of high-grade unclassified renal cell carcinoma to improve prognostication and management strategy.
11. Clinicopathologic and genomic characterization of parenchymal brain metastases (BM) in prostate cancer (PCa).
12. High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing.
13. Microsatellite instability in prostate cancer and response to immune checkpoint blockade.
14. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
15. Next-generation sequencing (NGS) of tissue and cell free DNA (cfDNA) to identify somatic and germline alterations in advanced prostate cancer.
16. Small cell carcinoma of the bladder (SCCB): Clinical, histopathologic, and genomic predictors of clinical outcomes.
17. A phase II study combining ipilimumab and degarelix with or without radical prostatectomy (RP) in men with newly diagnosed metastatic noncastration prostate cancer (mNCPC) or biochemically recurrent (BR) NCPC.
18. Intratumoral heterogeneity of ERBB2/HER2 expression in micropapillary urothelial carcinoma.
19. Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay.
20. Genomic characterization of primary and metastatic prostate cancer (PC) using a targeted next-generation sequencing assay.
21. Development of novel metastatic prostate cancer cell lines by “organoid” in vitro culture technology.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.